These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21663841)

  • 1. The metabolic syndrome in HIV.
    Worm SW; Lundgren JD
    Best Pract Res Clin Endocrinol Metab; 2011 Jun; 25(3):479-86. PubMed ID: 21663841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of non-HDL cholesterol with subclinical atherosclerosis in HIV-positive patients.
    Badiou S; Thiebaut R; Aurillac-Lavignolle V; Dabis F; Laporte F; Cristol JP; Mercie P;
    J Infect; 2008 Jul; 57(1):47-54. PubMed ID: 18554723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent predictors of metabolic syndrome in HIV-infected patients.
    Alencastro PR; Fuchs SC; Wolff FH; Ikeda ML; Brandão AB; Barcellos NT
    AIDS Patient Care STDS; 2011 Nov; 25(11):627-34. PubMed ID: 21936688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
    Nichols GA; Koro CE; Chan W; Bowlin SJ; Sprecher DL
    Clin Ther; 2006 Feb; 28(2):243-50. PubMed ID: 16678645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating and managing cardiovascular disease risk factors in HIV-infected patients.
    Top HIV Med; 2010 Dec; 18(5):164-8. PubMed ID: 21245517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triglyceride-to-HDL-cholesterol ratio and metabolic syndrome as contributors to cardiovascular risk in overweight patients.
    Marotta T; Russo BF; Ferrara LA
    Obesity (Silver Spring); 2010 Aug; 18(8):1608-13. PubMed ID: 20019684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risk factors are really linked in the metabolic syndrome: this phenomenon suggests clustering rather than coincidence.
    Aizawa Y; Kamimura N; Watanabe H; Aizawa Y; Makiyama Y; Usuda Y; Watanabe T; Kurashina Y
    Int J Cardiol; 2006 May; 109(2):213-8. PubMed ID: 16023231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM
    Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic syndrome and cardiovascular disease.
    Bonora E
    Ann Med; 2006; 38(1):64-80. PubMed ID: 16448990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors.
    Quijada Z; Paoli M; Zerpa Y; Camacho N; Cichetti R; Villarroel V; Arata-Bellabarba G; Lanes R
    Pediatr Diabetes; 2008 Oct; 9(5):464-71. PubMed ID: 18507788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex difference in development of diabetes and cardiovascular disease on the way from obesity and metabolic syndrome.
    Onat A; Hergenç G; Keleş I; Doğan Y; Türkmen S; Sansoy V
    Metabolism; 2005 Jun; 54(6):800-8. PubMed ID: 15931618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome in patients with hematological diseases.
    Annaloro C; Airaghi L; Saporiti G; Onida F; Cortelezzi A; Deliliers GL
    Expert Rev Hematol; 2012 Aug; 5(4):439-58. PubMed ID: 22992237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of metabolic syndrome in Danish patients with HIV infection: the effect of antiretroviral therapy.
    Hansen BR; Petersen J; Haugaard SB; Madsbad S; Obel N; Suzuki Y; Andersen O
    HIV Med; 2009 Jul; 10(6):378-87. PubMed ID: 19490178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks of cardiovascular disease in patients receiving antiretroviral therapy for HIV infection: implications for treatment.
    Steinhart CR; Emons MF
    AIDS Read; 2004 Feb; 14(2):86-90, 93-5. PubMed ID: 14997864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome determinants in an urban population from Brazil: social class and gender-specific interaction.
    Marquezine GF; Oliveira CM; Pereira AC; Krieger JE; Mill JG
    Int J Cardiol; 2008 Sep; 129(2):259-65. PubMed ID: 18036678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation.
    Onat A; Hergenç G; Türkmen S; Yazici M; Sari I; Can G
    Metabolism; 2006 Apr; 55(4):445-52. PubMed ID: 16546474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolic syndrome: definitions, prevalence and management.
    Levesque J; Lamarche B
    J Nutrigenet Nutrigenomics; 2008; 1(3):100-8. PubMed ID: 19776619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges associated with metabolic syndrome.
    Spinler SA
    Pharmacotherapy; 2006 Dec; 26(12 Pt 2):209S-217S. PubMed ID: 17125447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between physical activity, physical fitness and development of metabolic disorders.
    Andersen LB; Bugge A; Dencker M; Eiberg S; El-Naaman B
    Int J Pediatr Obes; 2011 Sep; 6 Suppl 1():29-34. PubMed ID: 21905813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.